Detailed answers about PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED founded?
PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED was officially incorporated on 3 July 2002 and is registered under company number 04476828. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED?
PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED's current status is Liquidation. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED do?
PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED operates in the following sector: 72190 - Other research and experimental development on natural sciences and engineering. This provides insight into the company's primary business activity and industry focus.
What is PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED's registered address?
The registered office address of PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED is 1580 PARKWAY SOLENT BUSINESS PARK, WHITELEY, FAREHAM, HAMPSHIRE, PO15 7AG. This is the official address filed with Companies House for legal and statutory correspondence.
Is PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED financially stable?
The most recent accounts for PHARMACEUTICAL DEVELOPMENT SERVICES LIMITED were made up to 30 September 2022, filed as MICRO ENTITY. Next accounts are due by 30 June 2024.